Status:
COMPLETED
Decreased Neuraxial Morphine After Cesarean Delivery
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Anesthesia
Eligibility:
FEMALE
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block
Detailed Description
Regional anesthesia has been associated with reduced opioid consumption after surgery. Cesarean delivery is one of the most commonly performed surgeries worldwide and women undergoing cesarean deliver...
Eligibility Criteria
Inclusion
- All women presenting for scheduled cesarean delivery who desire a QL block
Exclusion
- Women with pregnancies complicated by preeclampsia
- Women with pregnancies complicated by insulin-treated diabetes
- Women with pregnancies complicated by placental abnormalities
- Women with pregnancies complicated by a history of opioid use disorder
Key Trial Info
Start Date :
September 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04279054
Start Date
September 9 2020
End Date
July 5 2023
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB Women and Infants Center
Birmingham, Alabama, United States, 35233